Fogari R
G Ital Cardiol. 1980;10(12):1675-8.
Systolic intervals, heart rate (HR) and blood pressure (BP) were monitored before and after oral administration of dilazep in 28 patients with chronic coronary disease. Controls were performed before drug assumption and after two months of treatment. 16 patients were given dilazep in 100 mg doses three times a day; 12 patients in 50 mg doses three times a day. In the former group dilazep brought about a PEP reduction owing to a shortening of the isovolumic contraction time. Also we noticed a constant decrease of BP, both systolic and diastolic, the former tapering from 155 down to 143 mmHg, the latter from 88 to 81. In the 12 patients treated with 150 mg a day, we did not notice any relevant alteration relatable to the drug since systolic intervals and BP were unimpaired. These observations point to a positive inotropic effect and a moderate vasodilatatory effect caused by dilazep if administered in 300 mg doses a day.
对28例慢性冠心病患者口服地拉䓬前后的收缩期间期、心率(HR)和血压(BP)进行了监测。在用药前和治疗两个月后进行对照。16例患者每日3次服用100mg剂量的地拉䓬;12例患者每日3次服用50mg剂量的地拉䓬。在前一组中,地拉䓬由于等容收缩期时间缩短导致射血前期(PEP)缩短。我们还注意到收缩压和舒张压持续下降,收缩压从155mmHg逐渐降至143mmHg,舒张压从88mmHg降至81mmHg。在每日服用150mg治疗的12例患者中,由于收缩期间期和血压未受影响,我们未发现与药物相关的任何显著变化。这些观察结果表明,地拉䓬如果每日服用300mg剂量,会产生正性肌力作用和适度的血管舒张作用。